Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Acute Myeloid leukaemia AML is a fast-growing cancer of the bone marrow that disrupts blood cell production It differs from ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development ...

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

A research team has discovered a previously unknown mechanism that could explain why many patients with aggressive B-cell lymphoma do not respond to CAR-T cell therapy in the long term. The results of ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers ...

Learn more about secondary acute myeloid leukemia, including what to expect after diagnosis, how to take care of yourself, and how to find support.

The report indicates >25 clinical trials, with the highest phase being Phase II/III as of June 2025. The US and China lead with >20 trials. Gamma Delta T Cell therapy, promising in treating blood ...